Stocks
Theravance Biopharma, Inc.TBPH
NASDAQHealthcareBiotechnology$13.78-0.79%
Focused on respiratory and inflammatory diseases, the company develops and commercializes small‑molecule medicines and maintains royalty interests in partnered therapies. Its revenue base is largely tied to royalties from global sales of inhaled respiratory treatments developed with partners, alongs...
Market Cap: $698.3M52W Range: $7.90 – $21.03
Congressional Interest in Theravance Biopharma, Inc. (TBPH)
No congressional trades have been disclosed for Theravance Biopharma, Inc. (TBPH) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading TBPH?
No congressional trades found for this stock.